½ÃÀ庸°í¼­
»óǰÄÚµå
1675070

¼¼°èÀÇ Å¸¿ì¸° ½ÃÀå : ¼ºÀå, Àü¸Á, °æÀï ºÐ¼®(2025-2033³â)

Taurine Market - Growth, Future Prospects and Competitive Analysis, 2025 - 2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Acute Market Reports | ÆäÀÌÁö Á¤º¸: ¿µ¹® 173 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Ÿ¿ì¸° ½ÃÀå¿¡´Â ´Ù¾çÇÑ »ê¾÷¿¡¼­ ³Î¸® »ç¿ëµÇ´Â À¯±â È­ÇÕ¹°ÀΠŸ¿ì¸°ÀÇ »ý»ê ¹× À¯ÅëÀÌ Æ÷ÇԵ˴ϴÙ. Ÿ¿ì¸°Àº ȲÀ» ÇÔÀ¯ÇÑ ¾Æ¹Ì³ë»êÀ¸·Î ÀÎü¿Í ¸¹Àº µ¿¹° Á¶Á÷¿¡ ÀÚ¿¬ÀûÀ¸·Î Á¸ÀçÇÕ´Ï´Ù. ´Ü¹éÁú ÇÕ¼º¿¡´Â »ç¿ëµÇÁö ¾ÊÁö¸¸ ´ãÁó»ê °áÇÕ, Ä®½· Ç×»ó¼º À¯Áö, ½ÉÇ÷°ü°è ±â´É µî ¿©·¯ »ý¸®Àû ±â´É¿¡ ÇʼöÀûÀÔ´Ï´Ù. »ê¾÷ ¿ëµµ¿¡¼­ Ÿ¿ì¸°Àº ¸¹Àº °Ç°­»óÀÇ ÀÌÁ¡À¸·Î ÀÎÇØ ¿µ¾ç º¸ÃæÁ¦, ƯÈ÷ ¿¡³ÊÁö À½·á, À¯¾Æ¿ë Á¶Á¦ ºÐÀ¯ ¹× ¹Ý·Áµ¿¹° »ç·á·Î ÀϹÝÀûÀ¸·Î »ç¿ëµË´Ï´Ù. ¼¼°èÀÇ Å¸¿ì¸° ½ÃÀåÀº ¿¬Æò±Õ ¼ºÀå·ü(CAGR) 5.5%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀº ÁÖ·Î °Ç°­°ú À£ºù¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ Ÿ¿ì¸°À» Æ÷ÇÔÇÑ °Ç°­ º¸Á¶ ½Äǰ ¹× ±â´É¼º ½Äǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Ç߱⠶§¹®ÀÔ´Ï´Ù. Ÿ¿ì¸°À» ÁÖ¼ººÐÀ¸·Î ÇÏ´Â ¿¡³ÊÁö À½·á°¡ ³Î¸® º¸±ÞµÇ¾î ½Åü ´É·Â°ú ¿¡³ÊÁö ¼öÁØÀ» Çâ»ó½ÃŰ´Â °Íµµ ½ÃÀå ¼ºÀå¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¹Ý·Áµ¿¹° »ç·á ºÐ¾ß´Â Ÿ¿ì¸°ÀÇ ÁÖ¿ä »ç¿ëÀÚÀ̸ç, ƯÈ÷ Ÿ¿ì¸°ÀÌ Çʼö ¿µ¾ç¼ÒÀÎ °í¾çÀ̸¦ À§ÇÑ Á¦Ç°¿¡ Ÿ¿ì¸°ÀÌ ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù.

¿¡³ÊÁö À½·á ¹× °Ç°­º¸Á¶½Äǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡

Ÿ¿ì¸° ½ÃÀåÀÇ Áß¿äÇÑ ÃËÁø¿äÀÎÀº Àü ¼¼°è¿¡¼­ °Ç°­¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ¼º´É Çâ»ó Á¦Ç°¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¿¡³ÊÁö À½·á ¹× °Ç°­ º¸Á¶ ½Äǰ¿¡ Ÿ¿ì¸°ÀÇ ¹èÇÕÀÌ È®´ëµÇ°í ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. Ÿ¿ì¸°Àº Á¤½Å·Â°ú ½ÅüÀû Áö±¸·ÂÀ» Çâ»ó½ÃŰ´Â ´É·ÂÀÌ ÀÖÀ¸¸ç, Ȱµ¿ÀûÀÌ°í °Ç°­ ÁöÇâÀûÀÎ ¼ÒºñÀÚÀÇ ¶óÀÌÇÁ½ºÅ¸ÀÏ¿¡ ºÎÇÕÇϴ ǰÁú·Î ÁÖ¸ñ¹Þ°í ÀÖ½À´Ï´Ù. Ÿ¿ì¸°ÀÌ Àαâ ÀÖ´Â ¿¡³ÊÁö À½·áÀÇ ¼ººÐÇ¥¿¡ µîÀçµÇ¸é¼­ Ÿ¿ì¸°¿¡ ´ëÇÑ ¼ÒºñÀÚ ÀνÄÀÌ ³ô¾ÆÁ³À» »Ó¸¸ ¾Æ´Ï¶ó, À¯ÀÍÇÑ °Ç°­ º¸Á¶ ½ÄǰÀ¸·Î ¸í¼ºÀ» ¾ò°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ÀνÄÀº Ÿ¿ì¸°ÀÌ ½ÉÇ÷°ü °Ç°­°ú ±ÙÀ° ±â´ÉÀ» Áö¿øÇÏ´Â ¿ªÇÒÀ» ÇÏ´Â È­ÇÕ¹°À̶ó´Â ¿¬°ü¼º¿¡ ÀÇÇØ ´õ¿í °­È­µÇ¾úÀ¸¸ç, ÇÇÆ®´Ï½º ¾ÖÈ£°¡ ¹× ÀÏ»óÀûÀΠȰ·Â °­È­¸¦ ¿øÇÏ´Â °³ÀÎÀ» À§ÇÑ Á¦Á¦ÀÇ ÇʼöǰÀ¸·Î ÀÚ¸® Àâ°Ô µÇ¾ú½À´Ï´Ù.

È­Àåǰ ¹× ÆÛ½º³ÎÄɾî Á¦Ç°À¸·ÎÀÇ È®Àå

Ÿ¿ì¸° ½ÃÀåÀº È­Àåǰ ¹× ÆÛ½º³ÎÄÉ¾î »ê¾÷À¸·Î È®ÀåÇÒ ¼ö ÀÖ´Â Å« ±âȸ°¡ ÀÖ½À´Ï´Ù. Ÿ¿ì¸°ÀÇ Ç×»êÈ­ ÀÛ¿ëÀº ÇǺΠ¹× Çì¾î Äɾî Á¦Ç°¿¡ È¿°úÀûÀ̸ç, ¼¼Æ÷¸¦ ¼Õ»óÀ¸·ÎºÎÅÍ º¸È£Çϰí ÇǺΠ¿Ü°üÀ» °³¼±ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. È­Àåǰ »ê¾÷ÀÌ ´õ ³ªÀº °Ç°­ È¿°ú¸¦ ¾à¼ÓÇÏ´Â Á¦Ç°À¸·Î °è¼Ó ÁøÈ­ÇÏ´Â °¡¿îµ¥, Ÿ¿ì¸°ÀÇ »êÈ­ ½ºÆ®·¹½º¸¦ ¿ÏÈ­Çϰí ÇǺΠ¼¼Æ÷³» ¼öºÐ °ø±ÞÀ» ÃËÁøÇϴ Ÿ¿ì¸°ÀÇ ´É·ÂÀº »õ·Î¿î ¼ºÀåÀÇ ±æÀ» Á¦½ÃÇÒ °ÍÀÔ´Ï´Ù. È­Àåǰ¿¡ õ¿¬ ¼ººÐ°ú ±â´É¼º ¼ººÐÀ» µµÀÔÇÏ´Â Ãß¼¼´Â Ÿ¿ì¸°ÀÇ ¹èÇÕÀ» Áö¿øÇϸç, °Ç°­ ÁõÁø È¿°ú°¡ ÀÖ´Â ¹Ì¿ë Á¦Ç°À» ã´Â ¼ÒºñÀڵ鿡°Ô ¾îÇÊÇÒ ¼ö ÀÖÀ» °ÍÀÔ´Ï´Ù.

±ÔÁ¦¿Í ¾ÈÀü¿¡ ´ëÇÑ ¸é¹ÐÇÑ Á¶»ç

Ÿ¿ì¸° ½ÃÀåÀÇ ÁÖ¿ä ¾ïÁ¦¿äÀÎÀº ½Äǰ÷°¡Á¦ ¹× º¸ÃæÁ¦ ¼ººÐ°ú °ü·ÃµÈ ¾ö°ÝÇÑ ±ÔÁ¦¿Í ¾ÈÀü¼º¿¡ ´ëÇÑ ¸é¹ÐÇÑ Á¶»çÀÔ´Ï´Ù. Ÿ¿ì¸°ÀÇ ¸¹Àº ÀåÁ¡¿¡µµ ºÒ±¸Çϰí Ÿ¿ì¸°Àº ½ÂÀÎ ¹× »ç¿ë ¼öÁØÀÌ ¾ö°ÝÇÏ°Ô °ü¸®µÇ´Â ¿©·¯ ±¹°¡ÀÇ º¹ÀâÇÑ ±ÔÁ¦ »óȲÀ» ±Øº¹ÇØ¾ß ÇÕ´Ï´Ù. ƯÈ÷ °í¿ë·®ÀÇ Å¸¿ì¸° º¸ÃæÁ¦¸¦ Àå±â°£ ¼·ÃëÇßÀ» ¶§ ³ªÅ¸³ª´Â ¿µÇâ°ú ´Ù¾çÇÑ Á¦Çü¿¡ Æ÷ÇÔµÈ ´Ù¸¥ ¼ººÐ°úÀÇ »óÈ£ÀÛ¿ë¿¡ ´ëÇÑ ¿ì·Á°¡ Àֱ⠶§¹®ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±ÔÁ¦ ¹®Á¦´Â ½ÃÀå ÁøÀÔ°ú È®ÀåÀ» Áö¿¬½Ã۰í Á¦Á¶¾÷ü°¡ Ÿ¿ì¸°À» ÇÔÀ¯ÇÑ ½ÅÁ¦Ç°À» ½Å¼ÓÇϰí È¿À²ÀûÀ¸·Î Ãâ½ÃÇÏ´Â ´É·Â¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.

°ø±Þ¸Á ºÒ¾ÈÁ¤¼º°ú ¿øÀÚÀç Á¶´Þ

Ÿ¿ì¸° ½ÃÀåÀº °ø±Þ¸Á º¯µ¿°ú ¿øÀÚÀç Á¶´Þ¿¡ ´ëÇÑ ¹®Á¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. Ÿ¿ì¸°Àº ÁַΠȲ ÇÔÀ¯ ¾Æ¹Ì³ë»êÀÎ ½Ã½ºÅ×Àο¡¼­ ÇÕ¼ºµÇÁö¸¸, ½Ã½ºÅ×ÀÎ ÀÚüµµ ¾ÈÁ¤ÀûÀÌ°í ºñ¿ë È¿À²ÀûÀ¸·Î Á¶´ÞÇØ¾ß ÇÕ´Ï´Ù. ½Ã½ºÅ×ÀÎÀÇ °¡¿ë¼º°ú °¡°Ý º¯µ¿Àº Ÿ¿ì¸°ÀÇ »ý»ê ºñ¿ë°ú ¸®µå ŸÀÓ¿¡ Á÷Á¢ÀûÀÎ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ¶ÇÇÑ Å¸¿ì¸°°ø±Þ¸ÁÀº Àü ¼¼°è¿¡ °ÉÃÄ ÀÖÀ¸¹Ç·Î Á¦Á¶¾÷ü´Â ÁöÁ¤ÇÐÀû ±äÀå, ¹«¿ª Á¦ÇÑ, ¹°·ù È¥¶õ°ú °ü·ÃµÈ À§Çè¿¡ ³ëÃâµÇ¾î ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº °ø±Þ¸Á ¿î¿µÀÇ Àϰü¼º ºÎÁ·À¸·Î À̾îÁ® Ÿ¿ì¸° Á¦Á¶¾÷ü°¡ ¾ÈÁ¤ÀûÀÎ »ý»ê·®À» º¸ÀåÇÏ°í ¼¼°è ½ÃÀå¿¡¼­ °æÀï·ÂÀÖ´Â °¡°ÝÀ» À¯ÁöÇÏ´Â °ÍÀ» ¾î·Æ°Ô ¸¸µì´Ï´Ù.

À¯Çüº° ½ÃÀå ±¸ºÐ

Ÿ¿ì¸° ½ÃÀåÀÇ À¯Çüº° ºÎ¹®¿¡´Â ½Äǰ µî±Þ°ú ÀǾàǰ µî±ÞÀÌ ÀÖ½À´Ï´Ù. ½Äǰ µî±ÞÀº ¿¡³ÊÁö À½·á, ±â´É¼º À½·á, °Ç°­ º¸Á¶ ½Äǰ¿¡ ³Î¸® »ç¿ëµÇ¾î °¡Àå ³ôÀº ¸ÅÃâÀ» âÃâÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿ìÀ§´Â ½ÅüÀû, Á¤½ÅÀû ¼º´ÉÀ» Çâ»ó½ÃŰ´Â °Ç°­ ÁöÇâÀû ½Äǰ ¹× À½·á Á¦Ç°ÀÇ ÁÖ¿ä ¼ººÐÀ¸·Î Ÿ¿ì¸°¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ¼±È£µµ°¡ ³ô¾ÆÁ³±â ¶§¹®ÀÔ´Ï´Ù. ½Äǰ µî±ÞÀÇ Å¸¿ì¸°Àº ½ÉÀå ¹× ´« °Ç°­ À¯Áö¿¡ ÇʼöÀûÀÎ ¿µ¾ç¼ÒÀÎ ¹Ý·Áµ¿¹° »ç·á, ƯÈ÷ °í¾çÀÌ »ç·á¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÇÑÆí, Á¦¾à µî±ÞÀº Ÿ¿ì¸°ÀÇ Ä¡·á È¿°ú¿¡ ´ëÇÑ ¿¬±¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¿¬Æò±Õ ¼ºÀå·ü(CAGR)ÀÌ °¡Àå ³ôÀº ÀǾàǰ µî±ÞÀÌ °¡Àå ³ôÀº °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. Ÿ¿ì¸°ÀÌ ¼¼Æ÷ ±â´ÉÀ» °³¼±ÇÏ°í »êÈ­ ½ºÆ®·¹½º¿¡ ´ëÇ×ÇÏ´Â ¿ªÇÒÀ» °­Á¶ÇÏ´Â ÀÓ»ó ¿¬±¸¿¡ ÈûÀÔ¾î ½ÉÇ÷°ü °Ç°­, ´ç´¢º´ °ü¸® ¹× ½Å°æ º¸È£ Ä¡·á¸¦ À§ÇÑ ÀǾàǰ Á¦Á¦¿¡ ´ëÇÑ Àû¿ëÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. Ư¼ö Ä¡·á ºÐ¾ß¿¡¼­ °í¼øµµ Ÿ¿ì¸°¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ÀÌ ºÎ¹®ÀÇ ºü¸¥ ¼ºÀå¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¿ëµµº° ½ÃÀå ±¸ºÐ

¿ëµµº° ½ÃÀå ºÐ·ù´Â ÀÇ·á Á¦Ç°, ¹Ý·Áµ¿¹° »ç·á, ½Äǰ ¹× À½·á, ½Äǰ ¹× À½·á, ±âŸ·Î ³ª´¹´Ï´Ù. À½·á ºÐ¾ß´Â Ÿ¿ì¸°ÀÌ ¿¡³ÊÁö À½·á¿Í ±â´É¼º À½·á¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖÀ¸¸ç, °¡Àå ³ôÀº ¸ÅÃâÀ» âÃâÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¦Ç°Àº ÇÇÆ®´Ï½º ¾ÖÈ£°¡ ¹× ºü¸¥ ¿¡³ÊÁö º¸ÃæÀ» ¿øÇÏ´Â »ç¶÷µé »çÀÌ¿¡¼­ ³ôÀº Àα⸦ À¯ÁöÇϰí ÀÖÀ¸¸ç, Ÿ¿ì¸°Àº ÀÌ Ä«Å×°í¸®¿¡¼­ ÇʼöÀûÀÎ ¼ººÐÀ¸·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù. ¿¡³ÊÁö À½·á ½ÃÀåÀº ¸ðµç °èÃþ¿¡¼­ Áö¼ÓÀûÀ¸·Î ¼ºÀåÇϰí ÀÖÀ¸¸ç, Ÿ¿ì¸°Àº ÀÌ ºÐ¾ß¿¡¼­ ¸ÅÃâ ¸®´õ·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù. ÇÑÆí, ¹Ý·Áµ¿¹° »ç·á ºÐ¾ß´Â Ÿ¿ì¸°ÀÌ °³¿Í °í¾çÀÌÀÇ °Ç°­¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ º¸È£ÀÚµéÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Ÿ¿ì¸°ÀÌ ½ÉÀå °Ç°­À» À¯ÁöÇÏ°í ¹Ý·Áµ¿¹°ÀÇ È®À强 ½É±ÙÁõ°ú °°Àº Áõ»óÀ» ¿¹¹æÇÒ ¼ö ÀÖ´Ù´Â »ç½ÇÀÌ ¾Ë·ÁÁö¸é¼­ °í±Þ ¾Ö¿Ïµ¿¹° »ç·á ºê·£µå¿¡ Ÿ¿ì¸°ÀÌ Ã·°¡µÇ±â ½ÃÀÛÇß½À´Ï´Ù. ¶ÇÇÑ ¹Ý·Áµ¿¹°ÀÇ Àΰ£È­°¡ ¼¼°èÀûÀÎ µ¿ÇâÀ¸·Î ¶°¿À¸£¸é¼­ ¿µ¾ç °­È­ ¾Ö¿Ïµ¿¹° »ç·á Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áö¼ÓÀûÀ¸·Î Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ÀÌ ºÐ¾ßÀÇ ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á Á¦Ç° ºÐ¾ßµµ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, Ÿ¿ì¸°Àº ¿µ¾ç º¸ÃæÁ¦ ¹× Ä¡·á¿ë Á¦Á¦¿¡ ÷°¡µÇ¾î Àüü ½ÃÀå È®´ë¸¦ Áö¿øÇϰí ÀÖ½À´Ï´Ù.

Ÿ¿ì¸° ½ÃÀåÀÇ Áö¿ª µ¿Çâ ¹× °æÀï ±¸µµ

2024³â ¾Æ½Ã¾ÆÅÂÆò¾çÀº Ÿ¿ì¸° ½ÃÀå¿¡¼­ °¡Àå ³ôÀº ¸ÅÃâÀ» ¿Ã·È´Âµ¥, À̴ Ÿ¿ì¸°ÀÇ »ý»ê°ú ¼Òºñ¿¡¼­ ¿ìÀ§¸¦ Á¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. Áß±¹°ú ÀϺ»°ú °°Àº ±¹°¡µéÀº Ÿ¿ì¸° »ý»ê ´É·ÂÀÌ ³ô°í, ±¹³» ½ÃÀå°ú ±¹Á¦ ½ÃÀå¿¡ °ø±ÞÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀÇ ¿¡³ÊÁö À½·á, ±â´É¼º ½Äǰ, ¾Ö¿Ïµ¿¹° Äɾî Á¦Ç°¿¡ ´ëÇÑ ¼ö¿äµµ ÀÌ Áö¿ªÀÇ ¸ÅÃâ ÀÔÁö¸¦ °­È­Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¾Æ½Ã¾ÆÅÂÆò¾çÀº 2025-2033³â °¡Àå ³ôÀº ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀÇ ¿øµ¿·ÂÀº Áß»êÃþ Àα¸ Áõ°¡, °Ç°­ º¸Á¶ ½Äǰ¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ¾Ö¿Ïµ¿¹° ÄÉ¾î »ê¾÷ÀÇ ¼ºÀå¿¡ ±âÀÎÇÕ´Ï´Ù. ºÏ¹Ì´Â ¿¡³ÊÁö À½·á¿Í °Ç°­ º¸Á¶ ½Äǰ¿¡ ´ëÇÑ ²ÙÁØÇÑ ¼ö¿ä¿¡ ÈûÀÔ¾î ±Ù¼ÒÇÑ Â÷ÀÌ·Î ±× µÚ¸¦ À̾ú½À´Ï´Ù. ÀÌ Áö¿ªÀº ¶ÇÇÑ ÀÇ·á Á¦Ç°¿¡¼­ Ÿ¿ì¸°ÀÇ Ä¡·áÀû ¿ëµµ¿¡ ´ëÇÑ ¿¬±¸¿¡ ´ëÇÑ ÅõÀÚ È®´ë¿¡ ÈûÀÔ¾î ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. À¯·´Àº ¼º¼÷ÇÑ ½ÃÀåÀ¸·Î Ÿ¿ì¸°À» ÇÔÀ¯ÇÑ ¹Ý·Áµ¿¹° »ç·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áö¼ÓµÇ°í ÀÖÀ¸¸ç, ±â´É¼º ½Äǰ ¹× À½·á¿¡ Ÿ¿ì¸°À» Àû¿ëÇÏ´Â »ç·Ê°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ±â¾÷°£ °æÀï °ü°è

Ÿ¿ì¸° ½ÃÀåÀº Á¦Ç° Çõ½Å, ÆÄÆ®³Ê½Ê, Áö¿ªÀû È®Àå µî ´Ù¾çÇÑ Àü·«À» ÅëÇØ ½ÃÀå ÀÔÁö¸¦ °­È­Çϱâ À§ÇØ ´Ù¾çÇÑ Àü·«À» äÅÃÇϰí ÀÖ´Â ÁÖ¿ä ±â¾÷ÀÌ Æ¯Â¡ÀÔ´Ï´Ù. 2024³â ÁÖ¿ä ±â¾÷Àº ¼¼°è ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ »ý»ê ´É·ÂÀ» È®´ëÇÏ´Â µ¥ ÁÖ·ÂÇß½À´Ï´Ù. 2025-2033³â Ÿ¿ì¸° Á¦Á¶¾÷ü¿Í ½Äǰ ¹× À½·á ±â¾÷ °£ÀÇ Çù¾÷ÀÌ Áõ°¡ÇÏ¿© ¼ÒºñÀÚÀÇ ±âÈ£¿¡ ¸Â´Â Çõ½ÅÀûÀÎ Á¦ÇüÀ» °³¹ßÇϱâ À§ÇØ 2025-2033³â Ÿ¿ì¸° Á¦Á¶¾÷ü¿Í ½Äǰ ¹× À½·á ±â¾÷ °£ÀÇ Çù¾÷ÀÌ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Çù·ÂÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ±â¾÷Àº ¼¼°è ȯ°æ ±ÔÁ¦¿¡ ¸ÂÃß¾î Áö¼Ó°¡´ÉÇÑ »ý»ê ¹æ½Ä¿¡ ÅõÀÚÇÏ¿© Àå±âÀûÀÎ ¼ºÀåÀ» º¸ÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °Ç°­°ú À£ºù¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö´Â ½ÅÈï ½ÃÀåÀ¸·ÎÀÇ ÁøÃâµµ ¼¼°è Ÿ¿ì¸° ½ÃÀå¿¡¼­ °æÀï·ÂÀ» À¯ÁöÇϱâ À§ÇÑ Áß¿äÇÑ Àü·«ÀÌ µÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ³ë·ÂÀº Àüü ¿ëµµÀÇ Çõ½Å°ú ¼ºÀåÀ» °¡¼ÓÇÏ°í ¿¹Ãø ±â°£ Áß ½ÃÀå ÁÖµµ±ÇÀ» È®º¸ÇÒ ¼ö Àִ ż¼¸¦ °®Ãß°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

  • ºÐ¼® ³»¿ë
    • ºÐ¼®ÀÇ ¸ñÀû
    • ´ë»óÀÚ
    • ÁÖ¿ä Á¦°ø ³»¿ë
  • ½ÃÀå ¼¼ºÐÈ­
  • ºÐ¼® ¹æ¹ý
    • ´Ü°è I : 2Â÷ Á¶»ç
    • ´Ü°è II : 1Â÷ Á¶»ç
    • ´Ü°è III : Àü¹®°¡ ÆÐ³Î ¸®ºä
    • ÀüÁ¦Á¶°Ç
    • äÅÃÇÑ ¾îÇÁ·ÎÄ¡

Á¦2Àå °³¿ä

Á¦3Àå Ÿ¿ì¸° ½ÃÀå : °æÀï ºÐ¼®

  • ÁÖ¿ä º¥´õÀÇ ½ÃÀå Æ÷Áö¼Å´×
  • º¥´õ°¡ äÅÃÇÑ Àü·«
  • ÁÖ¿ä »ê¾÷ Àü·«

Á¦4Àå Ÿ¿ì¸° ½ÃÀå : °Å½Ã ºÐ¼®°ú ½ÃÀå ¿ªÇÐ

  • ¼­·Ð
  • ¼¼°èÀÇ Å¸¿ì¸° ½ÃÀå(±Ý¾× ±â¹Ý, 2023-2033³â)
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ÁÖ¿ä °úÁ¦
    • ÁÖ¿ä ±âȸ
  • ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎÀÇ ¿µÇ⠺м®
  • ½Ã¼Ò ºÐ¼®
  • Porter's Five Forces ¸ðµ¨
    • °ø±Þ¾÷ü ÆÄ¿ö
    • ¹ÙÀÌ¾î ÆÄ¿ö
    • ´ëüǰÀÇ À§Çù
    • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
    • °æÀï ±â¾÷ °£ °æÀï °ü°è
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû »óȲ
    • °æÁ¦Àû »óȲ
    • ±â¼úÀû »óȲ
    • ¹ýÀû »óȲ
    • »çȸÀû »óȲ

Á¦5Àå Ÿ¿ì¸° ½ÃÀå : À¯Çüº°(2023-2033³â)

  • ½ÃÀå °³¿ä
  • ¼ºÀ塤¸ÅÃ⠺м® : 2024³â vs 2033³â
  • ½ÃÀå ¼¼ºÐÈ­
    • ½Äǰ µî±Þ
    • ÀǾàǰ µî±Þ

Á¦6Àå Ÿ¿ì¸° ½ÃÀå : ¿ëµµº°(2023-2033³â)

  • ½ÃÀå °³¿ä
  • ¼ºÀ塤¸ÅÃ⠺м® : 2024³â vs 2033³â
  • ½ÃÀå ¼¼ºÐÈ­
    • ÀÇ·á Á¦Ç°
    • ¾Ö¿Ïµ¿¹° »ç·á
    • À½·á
    • ±âŸ

Á¦7Àå Ÿ¿ì¸° ½ÃÀå : Çü»óº°(2023-2033³â)

  • ½ÃÀå °³¿ä
  • ¼ºÀ塤¸ÅÃ⠺м® : 2024³â vs 2033³â
  • ½ÃÀå ¼¼ºÐÈ­
    • Á¤Á¦/ĸ½¶
    • ¾×ü ±â¹Ý ¼¼·³
    • ±âŸ

Á¦8Àå ºÏ¹ÌÀÇ Å¸¿ì¸° ½ÃÀå(2023-2033³â)

  • ½ÃÀå °³¿ä
  • Ÿ¿ì¸° ½ÃÀå : À¯Çüº°(2023-2033³â)
  • Ÿ¿ì¸° ½ÃÀå : ¿ëµµº°(2023-2033³â)
  • Ÿ¿ì¸° ½ÃÀå : Çü»óº°(2023-2033³â)
  • Ÿ¿ì¸° ½ÃÀå : Áö¿ªº°(2023-2033³â)
    • ºÏ¹Ì
      • ¹Ì±¹
      • ij³ª´Ù
      • ±âŸ ºÏ¹Ì Áö¿ª

Á¦9Àå ¿µ±¹¡¤EU ±¹°¡ÀÇ Å¸¿ì¸° ½ÃÀå(2023-2033³â)

  • ½ÃÀå °³¿ä
  • Ÿ¿ì¸° ½ÃÀå : À¯Çüº°(2023-2033³â)
  • Ÿ¿ì¸° ½ÃÀå : ¿ëµµº°(2023-2033³â)
  • Ÿ¿ì¸° ½ÃÀå : Çü»óº°(2023-2033³â)
  • Ÿ¿ì¸° ½ÃÀå : Áö¿ªº°(2023-2033³â)
    • ¿µ±¹¡¤EU ±¹°¡
      • ¿µ±¹
      • µ¶ÀÏ
      • ½ºÆäÀÎ
      • ÀÌÅ»¸®¾Æ
      • ÇÁ¶û½º
      • ±âŸ À¯·´ Áö¿ª

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çŸ¿ì¸° ½ÃÀå(2023-2033³â)

  • ½ÃÀå °³¿ä
  • Ÿ¿ì¸° ½ÃÀå : À¯Çüº°(2023-2033³â)
  • Ÿ¿ì¸° ½ÃÀå : ¿ëµµº°(2023-2033³â)
  • Ÿ¿ì¸° ½ÃÀå : Çü»óº°(2023-2033³â)
  • Ÿ¿ì¸° ½ÃÀå : Áö¿ªº°(2023-2033³â)
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
      • Áß±¹
      • ÀϺ»
      • Àεµ
      • È£ÁÖ
      • Çѱ¹
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç

Á¦11Àå ¶óÆ¾¾Æ¸Þ¸®Ä«Å¸¿ì¸° ½ÃÀå(2023-2033³â)

  • ½ÃÀå °³¿ä
  • Ÿ¿ì¸° ½ÃÀå : À¯Çüº°(2023-2033³â)
  • Ÿ¿ì¸° ½ÃÀå : ¿ëµµº°(2023-2033³â)
  • Ÿ¿ì¸° ½ÃÀå : Çü»óº°(2023-2033³â)
  • Ÿ¿ì¸° ½ÃÀå : Áö¿ªº°(2023-2033³â)
    • ¶óƾ¾Æ¸Þ¸®Ä«
      • ºê¶óÁú
      • ¸ß½ÃÄÚ
      • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä« Áö¿ª

Á¦12Àå Áßµ¿¡¤¾ÆÇÁ¸®Ä«Å¸¿ì¸° ½ÃÀå(2023-2033³â)

  • ½ÃÀå °³¿ä
  • Ÿ¿ì¸° ½ÃÀå : À¯Çüº°(2023-2033³â)
  • Ÿ¿ì¸° ½ÃÀå : ¿ëµµº°(2023-2033³â)
  • Ÿ¿ì¸° ½ÃÀå : Çü»óº°(2023-2033³â)
  • Ÿ¿ì¸° ½ÃÀå : Áö¿ªº°(2023-2033³â)
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
      • GCC
      • ¾ÆÇÁ¸®Ä«
      • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« Áö¿ª

Á¦13Àå ±â¾÷ °³¿ä

  • Hubei Grand Fuchi Pharmaceutical & Chemicals Co. Ltd.
  • Qianjiang Yongan Pharmaceutical Co. Ltd.
  • Taisho Pharmaceutical Holdings Co. Ltd.
  • Avanscure LifeSciences Pvt. Ltd.
  • Atlantic Chemicals Trading GmbH
  • The Honjo Chemical Corporation
KSA 25.03.21

The taurine market involves the production and distribution of taurine, an organic compound widely used in various industries. Taurine is a sulfur-containing amino acid that is found naturally in the human body and in many animal tissues. It is not used in protein synthesis but is essential for several physiological functions, including bile acid conjugation, maintenance of calcium homeostasis, and functioning of the cardiovascular system. In industrial applications, taurine is commonly used as a dietary supplement, particularly in energy drinks, infant formula, and pet food, due to its numerous health benefits. The global taurine market is projected to grow at a Compound Annual Growth Rate (CAGR) of 5.5%. This growth is primarily driven by increasing consumer awareness of health and wellness, which has boosted the demand for dietary supplements and functional foods containing taurine. The widespread popularity of energy drinks, which often feature taurine as a key ingredient to enhance physical performance and energy levels, also significantly contributes to market growth. Additionally, the pet food sector is a major user of taurine, especially in products formulated for cats, for whom taurine is an essential nutrient.

Growing Demand in Energy Drinks and Health Supplements

A significant driver for the taurine market is its expanding inclusion in energy drinks and health supplements, driven by the global rise in health consciousness and consumer demand for performance-enhancing products. Taurine is touted for its ability to improve mental performance and physical endurance, qualities that align well with the lifestyle of active, health-conscious consumers. The visibility of taurine in the ingredient lists of popular energy drinks has not only increased consumer awareness but also cemented its reputation as a beneficial health supplement. This perception is further reinforced by the compound's association with supportive roles in cardiovascular health and muscle function, making it a staple in formulations aimed at fitness enthusiasts and individuals seeking enhanced day-to-day vitality.

Expansion into Cosmetic and Personal Care Products

The taurine market has a significant opportunity to expand into the cosmetic and personal care industries. Taurine's antioxidant properties make it beneficial for skin and hair care products, helping to protect cells from damage and improve the appearance of the skin. As the cosmetic industry continues to evolve towards products that promise added health benefits, taurine's ability to mitigate oxidative stress and promote hydration within skin cells presents new avenues for growth. The trend towards incorporating natural and functional ingredients into cosmetic products supports the inclusion of taurine, appealing to consumers looking for beauty products with health-promoting properties.

Regulatory and Safety Scrutiny

A major restraint in the taurine market is the stringent regulatory and safety scrutiny associated with food additives and supplement ingredients. Despite its many benefits, taurine must navigate complex regulatory landscapes across different countries, where its approval and use levels are rigorously controlled. This scrutiny stems from concerns over the possible effects of long-term taurine supplementation, especially at high doses, as well as its interaction with other ingredients in various formulations. Such regulatory challenges can slow market entry and expansion, affecting manufacturers' ability to launch new taurine-containing products quickly and efficiently.

Supply Chain Variability and Raw Material Sourcing

The taurine market faces challenges related to supply chain variability and the sourcing of raw materials. Taurine is predominantly synthesized from cysteine, a sulfur-containing amino acid, which itself must be sourced reliably and cost-effectively. Fluctuations in the availability or price of cysteine can directly impact taurine production costs and lead times. Additionally, the global nature of the taurine supply chain exposes manufacturers to risks associated with geopolitical tensions, trade restrictions, and logistics disruptions. These factors can lead to inconsistencies in supply chain operations, making it difficult for taurine producers to guarantee stable production volumes and maintain competitive pricing in the global market.

Market Segmentation by Type

In the taurine market, segmentation by type includes Food Grade and Pharmaceutical Grade taurine. The Food Grade segment accounts for the highest revenue, driven by its extensive use in energy drinks, functional beverages, and dietary supplements. This dominance is attributed to the increasing consumer preference for taurine as a key ingredient in health-oriented food and beverage products that enhance physical and mental performance. Food Grade taurine is also widely adopted in pet food formulations, particularly for cats, where it is an essential nutrient for maintaining heart and eye health. Meanwhile, the Pharmaceutical Grade segment is experiencing the highest Compound Annual Growth Rate (CAGR), propelled by growing research into taurine's therapeutic benefits. Its applications in pharmaceutical formulations for cardiovascular health, diabetes management, and neuroprotective treatments are expanding, supported by clinical studies highlighting taurine's role in improving cellular functions and combating oxidative stress. The rising demand for high-purity taurine in specialized medical treatments contributes significantly to this segment's rapid growth.

Market Segmentation by Application

Regarding market segmentation by application, the categories include Health Care Products, Pet Food, Beverage, and Others. The Beverage segment generates the highest revenue due to the widespread use of taurine in energy drinks and functional beverages. These products remain highly popular among fitness enthusiasts and individuals seeking quick energy boosts, making taurine a vital ingredient in this category. The consistent growth of the energy drink market across all demographics has cemented taurine's position as a revenue leader in this application. On the other hand, the Pet Food segment is witnessing the highest CAGR, driven by increasing awareness among pet owners about the health benefits of taurine for cats and dogs. Taurine's role in maintaining heart health and preventing conditions such as dilated cardiomyopathy in pets has led to its inclusion in premium pet food brands. Additionally, as pet humanization trends grow globally, the demand for nutritionally enriched pet food products continues to rise, further boosting this segment's growth. The Health Care Products segment also plays a significant role, with taurine being incorporated into dietary supplements and therapeutic formulations, supporting overall market expansion.

Geographic Trends and Competitive Landscape in the Taurine Market

In 2024, Asia-Pacific generated the highest revenue in the taurine market, attributed to its dominance in taurine production and consumption. Countries such as China and Japan have significant taurine manufacturing capabilities, supplying both domestic and international markets. The region's strong demand for energy drinks, functional foods, and pet care products also bolsters its revenue position. Furthermore, the Asia-Pacific region is expected to experience the highest Compound Annual Growth Rate (CAGR) from 2025 to 2033. This growth is driven by the rising middle-class population, increasing awareness of dietary supplements, and expanding pet care industries. North America follows closely, driven by the steady demand for energy drinks and health supplements. The region also benefits from growing investments in research on taurine's therapeutic applications in healthcare products. Europe represents a mature market, with sustained demand for pet food enriched with taurine and growing adoption in functional beverages.

Competitive Dynamics Among Top Players

The taurine market features prominent players employing diverse strategies to strengthen their market presence, including product innovation, partnerships, and geographic expansion. In 2024, key players focused on expanding production capacities to meet growing global demand. Companies also prioritized developing high-purity taurine for pharmaceutical applications, catering to the rising demand for health care products. From 2025 to 2033, the market is expected to witness increased collaborations between taurine manufacturers and food and beverage companies to create innovative formulations tailored to evolving consumer preferences. Additionally, leading players are anticipated to invest in sustainable production methods to align with global environmental regulations, ensuring long-term growth. Expanding into emerging markets with growing health and wellness trends will also remain a key strategy for maintaining competitiveness in the global taurine market. These collective efforts are poised to drive innovation and growth across applications, securing market leadership in the forecast period.

Historical & Forecast Period

This study report represents an analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.

The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Taurine market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users & consumption volume, price, and value.

Geographical revenues generated by countries considered in the report

Micro and macro environment factors that are currently influencing the Taurine market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.

  • Market Segmentation
    • Type
  • Food Grade
  • Pharmaceutical Grade
    • Application
  • Health Care Products
  • Pet Food,
  • Beverage
  • Others
    • Form
  • Tablets/Capsules
  • Liquid-based Serum
  • Others
  • Region Segment (2023-2033; US$ Million)
  • North America
  • U.S.
  • Canada
  • Rest of North America
  • UK and European Union
  • UK
  • Germany
  • Spain
  • Italy
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East and Africa
  • GCC
  • Africa
  • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Taurine market?
  • What are the key investment pockets concerning product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2033.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Taurine market?
  • Which is the largest regional market for Taurine market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Taurine market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Taurine market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Taurine Market
  • 2.2. Global Taurine Market, By Type, 2024 (US$ Million)
  • 2.3. Global Taurine Market, By Application, 2024 (US$ Million)
  • 2.4. Global Taurine Market, By Form, 2024 (US$ Million)
  • 2.5. Global Taurine Market, By Geography, 2024 (US$ Million)
  • 2.6. Attractive Investment Proposition by Geography, 2024

3. Taurine Market: Competitive Analysis

  • 3.1. Market Positioning of Key Taurine Market Vendors
  • 3.2. Strategies Adopted by Taurine Market Vendors
  • 3.3. Key Industry Strategies

4. Taurine Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Taurine Market Value, 2023 - 2033, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. Taurine Market: By Type, 2023-2033, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2024 Versus 2033
  • 5.3. Market Segmentation
    • 5.3.1. Food Grade
    • 5.3.2. Pharmaceutical Grade

6. Taurine Market: By Application, 2023-2033, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2024 Versus 2033
  • 6.3. Market Segmentation
    • 6.3.1. Health Care Products
    • 6.3.2. Pet Food,
    • 6.3.3. Beverage
    • 6.3.4. Others

7. Taurine Market: By Form, 2023-2033, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2024 Versus 2033
  • 7.3. Market Segmentation
    • 7.3.1. Tablets/Capsules
    • 7.3.2. Liquid-based Serum
    • 7.3.3. Others

8. North America Taurine Market, 2023-2033, USD (Million)

  • 8.1. Market Overview
  • 8.2. Taurine Market: By Type, 2023-2033, USD (Million)
  • 8.3. Taurine Market: By Application, 2023-2033, USD (Million)
  • 8.4. Taurine Market: By Form, 2023-2033, USD (Million)
  • 8.5.Taurine Market: By Region, 2023-2033, USD (Million)
    • 8.5.1.North America
      • 8.5.1.1. U.S.
        • 8.5.1.1.1. Taurine Market: By Type, 2023-2033, USD (Million)
        • 8.5.1.1.2. Taurine Market: By Application, 2023-2033, USD (Million)
        • 8.5.1.1.3. Taurine Market: By Form, 2023-2033, USD (Million)
      • 8.5.1.2. Canada
        • 8.5.1.2.1. Taurine Market: By Type, 2023-2033, USD (Million)
        • 8.5.1.2.2. Taurine Market: By Application, 2023-2033, USD (Million)
        • 8.5.1.2.3. Taurine Market: By Form, 2023-2033, USD (Million)
      • 8.5.1.3. Rest of North America
        • 8.5.1.3.1. Taurine Market: By Type, 2023-2033, USD (Million)
        • 8.5.1.3.2. Taurine Market: By Application, 2023-2033, USD (Million)
        • 8.5.1.3.3. Taurine Market: By Form, 2023-2033, USD (Million)

9. UK and European Union Taurine Market, 2023-2033, USD (Million)

  • 9.1. Market Overview
  • 9.2. Taurine Market: By Type, 2023-2033, USD (Million)
  • 9.3. Taurine Market: By Application, 2023-2033, USD (Million)
  • 9.4. Taurine Market: By Form, 2023-2033, USD (Million)
  • 9.5.Taurine Market: By Region, 2023-2033, USD (Million)
    • 9.5.1.UK and European Union
      • 9.5.1.1. UK
        • 9.5.1.1.1. Taurine Market: By Type, 2023-2033, USD (Million)
        • 9.5.1.1.2. Taurine Market: By Application, 2023-2033, USD (Million)
        • 9.5.1.1.3. Taurine Market: By Form, 2023-2033, USD (Million)
      • 9.5.1.2. Germany
        • 9.5.1.2.1. Taurine Market: By Type, 2023-2033, USD (Million)
        • 9.5.1.2.2. Taurine Market: By Application, 2023-2033, USD (Million)
        • 9.5.1.2.3. Taurine Market: By Form, 2023-2033, USD (Million)
      • 9.5.1.3. Spain
        • 9.5.1.3.1. Taurine Market: By Type, 2023-2033, USD (Million)
        • 9.5.1.3.2. Taurine Market: By Application, 2023-2033, USD (Million)
        • 9.5.1.3.3. Taurine Market: By Form, 2023-2033, USD (Million)
      • 9.5.1.4. Italy
        • 9.5.1.4.1. Taurine Market: By Type, 2023-2033, USD (Million)
        • 9.5.1.4.2. Taurine Market: By Application, 2023-2033, USD (Million)
        • 9.5.1.4.3. Taurine Market: By Form, 2023-2033, USD (Million)
      • 9.5.1.5. France
        • 9.5.1.5.1. Taurine Market: By Type, 2023-2033, USD (Million)
        • 9.5.1.5.2. Taurine Market: By Application, 2023-2033, USD (Million)
        • 9.5.1.5.3. Taurine Market: By Form, 2023-2033, USD (Million)
      • 9.5.1.6. Rest of Europe
        • 9.5.1.6.1. Taurine Market: By Type, 2023-2033, USD (Million)
        • 9.5.1.6.2. Taurine Market: By Application, 2023-2033, USD (Million)
        • 9.5.1.6.3. Taurine Market: By Form, 2023-2033, USD (Million)

10. Asia Pacific Taurine Market, 2023-2033, USD (Million)

  • 10.1. Market Overview
  • 10.2. Taurine Market: By Type, 2023-2033, USD (Million)
  • 10.3. Taurine Market: By Application, 2023-2033, USD (Million)
  • 10.4. Taurine Market: By Form, 2023-2033, USD (Million)
  • 10.5.Taurine Market: By Region, 2023-2033, USD (Million)
    • 10.5.1.Asia Pacific
      • 10.5.1.1. China
        • 10.5.1.1.1. Taurine Market: By Type, 2023-2033, USD (Million)
        • 10.5.1.1.2. Taurine Market: By Application, 2023-2033, USD (Million)
        • 10.5.1.1.3. Taurine Market: By Form, 2023-2033, USD (Million)
      • 10.5.1.2. Japan
        • 10.5.1.2.1. Taurine Market: By Type, 2023-2033, USD (Million)
        • 10.5.1.2.2. Taurine Market: By Application, 2023-2033, USD (Million)
        • 10.5.1.2.3. Taurine Market: By Form, 2023-2033, USD (Million)
      • 10.5.1.3. India
        • 10.5.1.3.1. Taurine Market: By Type, 2023-2033, USD (Million)
        • 10.5.1.3.2. Taurine Market: By Application, 2023-2033, USD (Million)
        • 10.5.1.3.3. Taurine Market: By Form, 2023-2033, USD (Million)
      • 10.5.1.4. Australia
        • 10.5.1.4.1. Taurine Market: By Type, 2023-2033, USD (Million)
        • 10.5.1.4.2. Taurine Market: By Application, 2023-2033, USD (Million)
        • 10.5.1.4.3. Taurine Market: By Form, 2023-2033, USD (Million)
      • 10.5.1.5. South Korea
        • 10.5.1.5.1. Taurine Market: By Type, 2023-2033, USD (Million)
        • 10.5.1.5.2. Taurine Market: By Application, 2023-2033, USD (Million)
        • 10.5.1.5.3. Taurine Market: By Form, 2023-2033, USD (Million)
      • 10.5.1.6. Rest of Asia Pacific
        • 10.5.1.6.1. Taurine Market: By Type, 2023-2033, USD (Million)
        • 10.5.1.6.2. Taurine Market: By Application, 2023-2033, USD (Million)
        • 10.5.1.6.3. Taurine Market: By Form, 2023-2033, USD (Million)

11. Latin America Taurine Market, 2023-2033, USD (Million)

  • 11.1. Market Overview
  • 11.2. Taurine Market: By Type, 2023-2033, USD (Million)
  • 11.3. Taurine Market: By Application, 2023-2033, USD (Million)
  • 11.4. Taurine Market: By Form, 2023-2033, USD (Million)
  • 11.5.Taurine Market: By Region, 2023-2033, USD (Million)
    • 11.5.1.Latin America
      • 11.5.1.1. Brazil
        • 11.5.1.1.1. Taurine Market: By Type, 2023-2033, USD (Million)
        • 11.5.1.1.2. Taurine Market: By Application, 2023-2033, USD (Million)
        • 11.5.1.1.3. Taurine Market: By Form, 2023-2033, USD (Million)
      • 11.5.1.2. Mexico
        • 11.5.1.2.1. Taurine Market: By Type, 2023-2033, USD (Million)
        • 11.5.1.2.2. Taurine Market: By Application, 2023-2033, USD (Million)
        • 11.5.1.2.3. Taurine Market: By Form, 2023-2033, USD (Million)
      • 11.5.1.3. Rest of Latin America
        • 11.5.1.3.1. Taurine Market: By Type, 2023-2033, USD (Million)
        • 11.5.1.3.2. Taurine Market: By Application, 2023-2033, USD (Million)
        • 11.5.1.3.3. Taurine Market: By Form, 2023-2033, USD (Million)

12. Middle East and Africa Taurine Market, 2023-2033, USD (Million)

  • 12.1. Market Overview
  • 12.2. Taurine Market: By Type, 2023-2033, USD (Million)
  • 12.3. Taurine Market: By Application, 2023-2033, USD (Million)
  • 12.4. Taurine Market: By Form, 2023-2033, USD (Million)
  • 12.5.Taurine Market: By Region, 2023-2033, USD (Million)
    • 12.5.1.Middle East and Africa
      • 12.5.1.1. GCC
        • 12.5.1.1.1. Taurine Market: By Type, 2023-2033, USD (Million)
        • 12.5.1.1.2. Taurine Market: By Application, 2023-2033, USD (Million)
        • 12.5.1.1.3. Taurine Market: By Form, 2023-2033, USD (Million)
      • 12.5.1.2. Africa
        • 12.5.1.2.1. Taurine Market: By Type, 2023-2033, USD (Million)
        • 12.5.1.2.2. Taurine Market: By Application, 2023-2033, USD (Million)
        • 12.5.1.2.3. Taurine Market: By Form, 2023-2033, USD (Million)
      • 12.5.1.3. Rest of Middle East and Africa
        • 12.5.1.3.1. Taurine Market: By Type, 2023-2033, USD (Million)
        • 12.5.1.3.2. Taurine Market: By Application, 2023-2033, USD (Million)
        • 12.5.1.3.3. Taurine Market: By Form, 2023-2033, USD (Million)

13. Company Profile

  • 13.1. Hubei Grand Fuchi Pharmaceutical & Chemicals Co., Ltd.
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Portfolio
    • 13.1.4. Strategic Initiatives
  • 13.2. Qianjiang Yongan Pharmaceutical Co., Ltd.
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Portfolio
    • 13.2.4. Strategic Initiatives
  • 13.3. Taisho Pharmaceutical Holdings Co., Ltd.
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Portfolio
    • 13.3.4. Strategic Initiatives
  • 13.4. Avanscure LifeSciences Pvt. Ltd.
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Portfolio
    • 13.4.4. Strategic Initiatives
  • 13.5. Atlantic Chemicals Trading GmbH
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Portfolio
    • 13.5.4. Strategic Initiatives
  • 13.6. The Honjo Chemical Corporation
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Portfolio
    • 13.6.4. Strategic Initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦